tiprankstipranks
Trending News
More News >

Diana Brainard Insider Profile

4 Followers
Diana Brainard, CEO, Director at Kalaris Therapeutics, holds 723.36K shares in Kalaris Therapeutics (Ticker: KLRS), holds 28.56K shares in Nektar Therapeutics (Ticker: NKTR). Most recently, Diana Brainard Sold ― shares of Kalaris Therapeutics on Nov 20, 2024 for an estimated value of $4.70K.
tipranks
Diana Brainard

Diana Brainard
Kalaris Therapeutics (KLRS)
CEO, Director

Ranked #183 out of 106,324 Corporate Insiders

Profitable Transactions

93%
26 out of 28 Profitable Transactions

Average Return

+61.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$9M
77.78%
22.22%
A breakdown of Diana Brainard's holdings

Insider Roles

Kalaris Therapeutics
(KLRS)
CEO, Director
Nektar Therapeutics
(NKTR)
Director
Roles that Diana Brainard holds in companies

Most Profitable Insider Trade

Stock:
Kalaris Therapeutics
(KLRS)
Rating:Informative Sell
Date:Aug 22, 2024 - Aug 22, 2025
Return:+85.70%
The most profitable trade made by Diana Brainard

Diana Brainard's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Kalaris Therapeutics
Nov 20, 2024
CEO, Director
Informative Sell
4.70K
$7.20M
Nektar Therapeutics
Sep 20, 2022
Director
Uninformative Buy
$2.06M
List of latest transactions for each holding click on a transaction to see Diana Brainard's performance on stock

Diana Brainard insider profile FAQ

What is the percentage of profitable transactions made by Diana Brainard?
The percentage of profitable transactions made by Diana Brainard is 93%.
    What is the average return per transaction made by Diana Brainard?
    The average return per transaction made by Diana Brainard is 61.10%.
      What stocks does Diana Brainard hold?
      Diana Brainard holds: KLRS, NKTR stocks.
        What was Diana Brainard’s latest transaction?
        Diana Brainard latest transaction was an Informative Sell of $4.70K.
          What was Diana Brainard's most profitable transaction?
          Diana Brainard’s most profitable transaction was an Informative Sell of KLRS stock on August 22, 2024. The return on the trade was 85.70%.
            What is Diana Brainard's role in Kalaris Therapeutics?
            Diana Brainard's role in Kalaris Therapeutics is CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.